The recent surge in prescriptions for ivermectin and fenbendazole, two antiparasitic drugs, has sparked a heated debate in the medical community. The surge in interest was largely fueled by actor Mel Gibson's claim on the Joe Rogan Experience podcast that these drugs can treat cancer. While the idea of a simple, low-cost solution to a complex disease like cancer is alluring, the scientific community remains cautious. The article delves into the current state of research, highlighting the need for further clinical trials and the potential dangers of self-medication. It also explores the psychological and cultural factors driving the interest in these drugs, and the potential implications for the future of cancer treatment.
